Filing Details

Accession Number:
0001415889-22-005252
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 18:02:25
Reporting Period:
2022-05-18
Accepted Time:
2022-05-18 18:02:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
812796 Soligenix Inc. SNGX Pharmaceutical Preparations (2834) 411505029
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1595197 Richard Straube C/O Soligenix, Inc.
29 Emmons Drive, Suite B-10
Princeton NJ 08540
Senior Vice President And Cmo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-18 8,000 $0.50 8,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct